• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Accent Therapeutics Presents ATX-295 Data at 2026 AACR Meeting

    FIRSTWORD PHARMA

    Accent Therapeutics to Show ATX-295 Data at AACR 2026

    PR NEWSWIRE

    Accent Halts DHX9 Inhibitor Trial Over Adverse Events

    FIERCE BIOTECH

    Accent Therapeutics Leverages Inocras Platforms in ATX-295 Study

    BUSINESSWIRE

    Accent Therapeutics Unveils Preclinical Data On ATX-295

    PR NEWSWIRE

    Accent Therapeutics Trial in Progress Poster for ATX-559 at 2025

    PR NEWSWIRE

    Accent Announces 1st Patient Dosed in Ph 1/2 of Novel KIF18A Inhibitor

    PR NEWSWIRE

    Accent Therapeutics to Present Data Supporting DHX9 Inhibition at AACR Meeting

    PR NEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.